Table 3 Influence of miRNAs on the... | American Society of Hematology

Table 3

Influence of miRNAs on the clinical multivariate model for outcome prediction

	Hazard ratio	95% CI	P
Overall survival*
miR-191 high expression	2.35	1.18-4.75	.01
miR-199 high expression	2.81	0.96-8.23	.05
Adverse cytogenetics	2.31	0.85-6.29	.09
Event-free survival†
miR-199 high expression	2.57	0.89-2.57	.08
miR-191 high expression	2.29	1.15-4.55	.01
Adverse cytogenetics	1.78	0.66-1.49	.24

	Hazard ratio	95% CI	P
Overall survival*
miR-191 high expression	2.35	1.18-4.75	.01
miR-199 high expression	2.81	0.96-8.23	.05
Adverse cytogenetics	2.31	0.85-6.29	.09
Event-free survival†
miR-199 high expression	2.57	0.89-2.57	.08
miR-191 high expression	2.29	1.15-4.55	.01
Adverse cytogenetics	1.78	0.66-1.49	.24

Likehood ratio: 26.1 on 3 df (P < .001).

Likelihood ratio: 20.76 on 3 df (P < .001).